|Bid||0.00 x 1300|
|Ask||0.00 x 4000|
|Day's range||12.60 - 13.20|
|52-week range||11.44 - 19.02|
|Beta (5Y monthly)||1.36|
|PE ratio (TTM)||N/A|
|Earnings date||21 Feb 2022 - 25 Feb 2022|
|Forward dividend & yield||1.20 (8.92%)|
|Ex-dividend date||10 Feb 2022|
|1y target est||15.77|
These income stocks, with yields ranging from 7.3% to 11.6%, can make long-term investors a lot richer.
Sabra (SBRA) delivered FFO and revenue surprises of 2.63% and 1.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
IRVINE, Calif., May 04, 2022--Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2022. In addition, the Company provided a business update.